This program will emphasize the evidence-based strategy for the current treatments of the neurological disorders and cutting edge research in novel therapeutics. It will cover new methodologies and advancement in diagnosis and treatment of patients with Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, headache, neuromuscular disorders, sleep disorders, and others.